Urachal adenocarcinoma: a rare bladder tumor management

Cover Page

Cite item

Full Text

Abstract


Urachal adenocarcinoma is a rare and aggressive form of non-urothelial carcinoma. It commonly encountered the bladder at the dome or along its midline. Adenocarcinoma histology with frequent mucinous or signet ring cell features distinguishes it from traditional urothelial tumours. It usually manifests in adults aged 47 to 56, with an even distribution between genders. It constitutes about 0.5 to 2 % of all bladder malignancies. Surgery remains the primary treatment modality in prolonging patients’ overall survival time. We wish to discuss a case of a patient diagnosed with urachal adenocarcinoma.

About the authors

M. Pannirselvam

Universiti Sains Malaysia

Email: manivaasan.p@gmail.com
ORCID iD: 0000-0003-0980-8068

Department of Surgery, School of Medical Sciences, Universti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Malaysia

M. A. M. Daud

Universiti Sains Malaysia;
Hospital Universiti Sains Malaysia

Hospital Universiti Sains Malaysia; Urology Unit, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Malaysia

M. F. Othman

Universiti Sains Malaysia;
Hospital Universiti Sains Malaysia

Author for correspondence.
Email: faeid@usm.my
ORCID iD: 0000-0002-7674-2663

Muhammad Faeid Othman 

Hospital Universiti Sains Malaysia; Urology Unit, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Malaysia

A. F. N. M. Ghazi

Universiti Sains Malaysia;
Hospital Universiti Sains Malaysia

Hospital Universiti Sains Malaysia; Urology Unit, Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Malaysia

S. S. Tan

Universiti Sains Malaysia

Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Malaysia

G. C. Teh

Sarawak General Hospital

Department of Urology

Kuching, Sarawak, Malaysia

Malaysia

References

  1. Begg R.C. The urachus: its anatomy, histology and development. J Anat 1930;64(Pt 2):170–83.
  2. Scabini S., Rimini E., Romairone E. et al. Urachal tumour: case report of a poorly understood carcinoma. World J Surg Oncol [Internet] 2009 [cited 2023];7(1):1–3. Available at: https://wjso.biomedcentral.com/articles/10.1186/1477-7819-7-82
  3. Schubert G.E., Pavkovic M.B., Bethke-Bedurftig B.A. Tubular urachal remnants in adult bladders. J Urol 1982;127(1):40–2. doi: 10.1016/s0022-5347(17)53595-8
  4. Sheldon C.A., Clayman R.V., Gonzalez R. et al. Malignant urachal lesions. J Urol 1984;131(1):1–8. doi: 10.1016/s0022-5347(17)50167-6
  5. Pinthus J.H., Haddad R., Trachtenberg J. et al. Population based survival data on urachal tumors. J Urol 2006;175(6):2042–7. doi: 10.1016/S0022-5347(06)00263-1
  6. Ghazizadeh M., Yamamoto S., Kurokawa K. Clinical features of urachal carcinoma in Japan: review of 157 patients. Urol Res 1983;11(5):235–8. doi: 10.1007/BF00272286
  7. Siefker-Radtke A.O., Gee J., Shen Y. et al. Multimodality management of urachal carcinoma: the M.D. Anderson Cancer Center experience. J Urol 2003;169(4):1295–8. doi: 10.1097/01.ju.0000054646.49381.01
  8. Molina J.R., Quevedo J.F., Furth A.F. et al. Predictors of survival from urachal cancer. Cancer 2007;110(11):2434–40. doi: 10.1002/cncr.23070
  9. Ashley R.A., Inman B.A., Sebo T.J. et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 2006;107(4):712–20. doi: 10.1002/cncr.22060
  10. Siefker-Radtke A. Urachal carcinoma: surgical and chemotherapeutic options. Expert Rev Anticancer Ther 2014;6(12):1715–21. doi: 10.1586/14737140.6.12.1715
  11. Wong-You-Cheong J.J., Woodward P.J., Manning M.A., Sesterhenn I.A. Neoplasms of the urinary bladder: radiologicpathologic correlation. Radiographics 2006;26(2):553–80. doi: 10.1148/rg.262055172
  12. Gopalan A., Sharp D.S., Fine S.W. et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 2009;33(5):659–68. doi: 10.1097/PAS.0b013e31819aa4ae
  13. Singh I., Prasad R. Primary urachal mucinous adenocarcinoma of the urinary bladder. J Clin Diagn Res 2013;7(5):911–3. doi: 10.7860/JCDR/2013/5597.2973
  14. Henly D.R., Farrow G.M., Zincke H. Urachal cancer: role of conservative surgery. Urology 1993;42(6):635–9. doi: 10.1016/0090-4295(93)90526-g
  15. Herr H.W., Bochner B.H., Sharp D. et al. Urachal carcinoma: contemporary surgical outcomes. J Urol 2007;178(1):74–8. doi: 10.1016/j.juro.2007.03.022
  16. Elser C., Sweet J., Cheran S.K. et al. A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens. Can Urol Assoc J 2012;6(1):E27–31. doi: 10.5489/cuaj.11109

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.